19603031

Source:http://linkedlifedata.com/resource/pubmed/id/19603031

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008838, umls-concept:C0205179, umls-concept:C0205420, umls-concept:C0282460, umls-concept:C0684249, umls-concept:C0879262, umls-concept:C1517927, umls-concept:C1522449
pubmed:issue	2
pubmed:dateCreated	2009-7-15
pubmed:abstractText	To assess the efficacy and safety of S-1 and cisplatin with concurrent thoracic radiation for unresectable stage III non-small-cell lung cancer (NSCLC).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-10226579, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-10561343, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-10655437, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-10841143, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-10894878, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-11081568, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-11592762, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-12377962, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-12538461, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-12743155, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-12942107, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-12942110, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-1310160, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-1447744, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-14725747, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-15172641, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-15364136, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-15585618, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-16087941, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-16087956, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-17237035, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-1847977, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-18487565, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-18506025, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-19056143, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-2702835, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-9607565, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-9735397, http://linkedlifedata.com/resource/pubmed/commentcorrection/19603031-9779707
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370635
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid, http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination), http://linkedlifedata.com/resource/pubmed/chemical/Tegafur
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1532-1827
pubmed:author	pubmed-author:EndoMM, pubmed-author:GomiKK, pubmed-author:HaradaHH, pubmed-author:HoraiTT, pubmed-author:HoriikeAA, pubmed-author:KozukaTT, pubmed-author:MorotaMM, pubmed-author:MurakamiHH, pubmed-author:NakamuraYY, pubmed-author:NishimuraTT, pubmed-author:NishioMM, pubmed-author:OhyanagiFF, pubmed-author:TakahashiTT, pubmed-author:TsuyaAA, pubmed-author:YamamotoNN
pubmed:issnType	Electronic
pubmed:day	21
pubmed:volume	101
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	225-31
pubmed:dateRevised	2010-9-24
pubmed:meshHeading	pubmed-meshheading:19603031-Adult, pubmed-meshheading:19603031-Aged, pubmed-meshheading:19603031-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19603031-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:19603031-Cisplatin, pubmed-meshheading:19603031-Combined Modality Therapy, pubmed-meshheading:19603031-Disease-Free Survival, pubmed-meshheading:19603031-Drug Combinations, pubmed-meshheading:19603031-Female, pubmed-meshheading:19603031-Humans, pubmed-meshheading:19603031-Lung Neoplasms, pubmed-meshheading:19603031-Male, pubmed-meshheading:19603031-Middle Aged, pubmed-meshheading:19603031-Neoplasm Staging, pubmed-meshheading:19603031-Oxonic Acid, pubmed-meshheading:19603031-Survival Rate, pubmed-meshheading:19603031-Tegafur
pubmed:year	2009
pubmed:articleTitle	Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
pubmed:affiliation	Thoracic Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan.
pubmed:publicationType	Journal Article, Clinical Trial, Phase II